Hematologic Disorders in Maternal-Fetal Medicine
نویسندگان
چکیده
منابع مشابه
Fetal laboratory medicine: on the frontier of maternal-fetal medicine.
BACKGROUND Emerging antenatal interventions and care delivery to the fetus require diagnostic support, including laboratory technologies, appropriate methodologies, establishment of special algorithms, and interpretative guidelines for clinical decision-making. CONTENT Fetal diagnostic and therapeutic interventions vary in invasiveness and are associated with a spectrum of risks and benefits....
متن کاملMetabolomics Application in Maternal-Fetal Medicine
Metabolomics in maternal-fetal medicine is still an "embryonic" science. However, there is already an increasing interest in metabolome of normal and complicated pregnancies, and neonatal outcomes. Tissues used for metabolomics interrogations of pregnant women, fetuses and newborns are amniotic fluid, blood, plasma, cord blood, placenta, urine, and vaginal secretions. All published papers highl...
متن کاملBest practice in maternal-fetal medicine.
Recent developments have changed many previous assumptions about the best options for management of pregnancy and childbirth, therefore FIGO aims to provide leadership and clarity for the application of the new (and relatively new) techniques and clinical options that are now available to clinicians for the successful management of the pregnant mother and her fetus/newborn. Although these issue...
متن کاملLaboratory maternal-fetal medicine: challenges and perspectives.
Pregnancy-related disorders which typically include gestational or pregnancy diabetes, hypertensive or high blood pressure-related conditions (i.e., chronic hypertension, preeclampsia-eclampsia, preeclampsia superimposed on chronic hypertension and gestational hypertension), stillbirth and abnormal size of babies at birth (top and bottom 10 % in weight) offer an invaluable opportunity for diagn...
متن کاملMaternal serum screening for fetal genetic disorders.
Maternal serum analyte screening is an integral component of contemporary antenatal care. Based on elevated MSAFP levels, 85% to 90% of NTDs (e.g., anencephaly or spina bifida) can be detected. Using a combination of serum analytes (e.g., MSAFP, hCG, UE3) 55% to 60% of fetal Down's syndrome can be detected. Future strategies for Down's syndrome screening may include the use of new markers such ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Pathology
سال: 1991
ISSN: 0021-9746
DOI: 10.1136/jcp.44.8.704-a